References
- W.J.CatalonaA.W.PartinK.M.SlawinM.K.BrawerR.C.FlaniganA.PateletalUse of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trialJAMA279199815421547
- J.E.FowlerJr.J.SandersS.A.BiglerJ.RigdonN.K.KilambiS.LandA percent free prostate specific antigen and cancer detection in black and white men with total prostate specific antigen 2.5 to 9.9 ng/mlJ Urol163200014671470
- E.V.EzenwaK.H.TijaniE.A.JejeS.O.OyetunjiM.A.OgunjimiR.W.OjewolaetalThe value of percentage free prostate-specific antigen (PSA) in the detection of prostate cancer among patients with intermediate levels of total PSA (4.0–10.0 ng/mL) in NigeriaArab J Urol2012 (Epub ahead of print)